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Introduction
At present one of the most cumbersome problems is to treat serious pulmonary
tuberculosis patients for whom surgical operations are not efficacious and whose
bacilli have become resistant to Streptomycin (SM), Para-aminosalicylic acid (PAS)
and Isonicotinic acid hydrazide (INH).
In 1954, a new antibiotic substance, Cycloserine (CS) was isolated by Harned
and associates1,2,3) from cultures of Streptomyces orchidaceus. This antibiotic shows
definite tuberculostatic activity in vitro and in vivo, though not so powerful as
•
SM or INH.
In 1955, another new antibiotic substance, Kanamycin (KM) was isolated by
Umezawa and associates4 ,5) from cultures of Streptomyces kanamyceticus, and was
clearly demonstrated to have nearly equal tuberculostatic activity to SM.G)
The combined use of KM and CS would be expected to bring about
favorable effect on such serious pulmonary tuberculosis.
In this paper, the results of the experimental studies on the antituberculous
activity of KM-CS in vitro and in animals will be reported.
Experiments
(I) The tuberculostatic activity of KM-CS in vitro.
Methods:
The minimal inhibitory concentration (MIC) of KM-CS was compared with
that of KM or CS alone.
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The culture medium employed was Kirchner's liquid medium containing bovine
serum in the concentration of 10 per cent. The pH, when required, was adjusted
to 5.5, 6.5 and 7.5.
Serial dilutions of the drugs were made with the Kirchner's media.
Tubes with 2 m!. of the media containing serially diluted drugs and control
tubes were inoculated with tubercle bacilli (H37Rv) in the amount of 0.1 mg.,
0.01 mg. or 0.001 mg. per ml. of the media.
All tubes were incubated at 37°C. At the end of the first month, the tubes
were examined and the MIC was recorded.
Results:
Table 1 shows the results of KM-CS used at the rate of each clinical dose
(1 to 1). The MIC of KM increased with the increase of the size of inocula and
also in acid media while that of CS was less influenced by these factors. The MIC
of KM-CS decreased to one half of that used alone when a larger inoculum






Table 1. Tuberculostatic Effect of Kanamycin-Cycloserine at the Combination Rate
of Each Clinical Dose (1 to 1).
Materials 1-~HI5~sr::(~~~K~Hi7is-II~;5~S E::r;~ 1.1K:/~S
KM I 5.0: I 2.5'1 11.25 II 5.0 2.5: I, 1.25 "
CS I 1'12.5 i !12.5 [ 12.5 I[ 12.5 1,12.5 I 12.5




KM . 1.25 I I 1.25 I 0.625 I, 1.25 [ 1.26 \ 12.5 \ 0.625: \
CS ' 112.5 I 112.5 12.5 I [12.5' I I 112.5 I~M-CS L25I1.251 06251 0.625 03133B13! .. ~2~ i L25 _I ~.62~1 0625 _0~62t06251
KM 0.625\ I 0.625 I 0.313 I 0.625 I 0.625 1, 0.625! I
CS I' 112.5 I 12.5 I 12.5 il ,12.5 I, i12.~ 112.5 I
KM-CS _ 0~25L0.6251 0~6251 0.625 0.313\ 0.31311 0.625' 0.6251 C~~~:~ll- 0.625, 0.625
1
Numerals indicate the MIC in y per m!.
Table 2. Tuberculostatic Effect of Kanamycin-Cycloserine at the Combination Rate






_- Experiment i-II Experiment 2\K~lrg~s IK:r~s-l :~01m~~ rK~lrg~s -i K~~"'~di~Ot~-
2.5! 11.25 I 1.25 :1 2.5 1.25 I 1-.25 I
I 12.5 12.5 : 12.5 il i 25.0 25.0 I I 25.0
0.625 i 6.25 1 0.625 I 6.25 0.625 6.25 [; 0.625 I 6.25 I 0.313 3.13 I 0.313! 3.13
Numerals indicate the MIC in y per m!.
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Table 2 shows the results of KM-CS used at the rate of each MIC (1 to 10).
KM-CS demonstrates the synergistic effect to a certain extent in every inoculum
size in this experiment.
(II) Development of the resistance of Mycobacterium tuberculosis to KM and CS
transferred successively in media containing fixed doses of the drugs.
Methods:
Tubes with 2 mI. of Kirchner's medium containing serially diluted concentra-
tions of KM, CS and/or KM-CS (at the rate of 1 to 1) were inoculated with
0.1 mg. of tubercle bacilli (H37Rv).
Three tubes were used for each concentration of the drugs.
After one month's incubation at 37°C, the supernatant was removed aseptically
and the sediment of one of these three tubes was used for the sensitivity test
to KM and CS employing the egg media.
The sediments of the other tubes were resuspended in newly prepared media
containing the same concentration of the drugs as the former ones in order to
prevent the decrease of potency of the drugs as possible.
Results:
The results are shown in table 3. When the bacilli were incubated in a
medium containing KM in the concentration of 1001 per mI., the bacterial resistance
Table 3. Development of Resistance of H 37 Rv to Kanamycin and Cycloserine in







I Drug Sensitivity after
1 __ -=~~~th:_*__ 1 2 Months 3 Months









n.G. n.G. n.G. n.G. n.G. n.G.
5.0 12.5 5.0 12.5 n.G. n.G.
2.5 6.25 2.5 6.25 2.5 12.5
* Numerals indicate the MIC in ')' per ml.
** n.G. means no growth of the incubated organisms. Therefore sensitivity test was
not performed.
*** Renewal of the media (drugs) was performed at the end of each month.
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to KM developed to lOr per ml. after one month.
After 2 months the drug-sensitivity test to KM was not determined because
the growth of the organisms was not observed even in the control egg media
(without KM). This may be due to the bactericidal effect of the drug.
When the bacilli were incubated in media containing KM in lower concentra-
tions, the resistance of the organisms to KM developed rapidly up to 50r per ml.
after two successive transfers.
When the organisms were inoculated in media containing KM or CS each in
the concentration of 100r per mI., no growth was found after one month. This
might be due to the enhanced bactericidal activity of KM by the addition of CS.
When the organisms were inoculated into media containing lower concentra-
tions of KM-CS, their growth was observed but no development of drug-resistance
was recognized even after two successive transfers.
(III) The tuberculostatic activity in the serum of the rabbits after the administ-
ration of KM-CS.
Methods:
Five rabbits, each weighing approximately 3 kg. were employed and they were
fasted on the day of drug administration.
The test dosage of CS (20 mg. per kg.) was dissolved in 5 ml. of water and
poured into the stomach of the rabbits by Nelaton's catheter, and that of KM
(20 mg. per kg.) was injected intramuscularly in the back.
The blood samples for the test were collected aseptically before the drug-
administration as controls and 1, 3, 5, 7 and 9 hours after the administration of
the drugs and allowed to stand for 24 hours.
Then the sera were separated from these samples by centrifugation, and the
modified Kirchner's media added with sera in the concentration of 90 per cent
were prepared by Shioda's method7 ) for each series of the experiment.
The medium thus obtained is composed of 0.1 ml. of the modified Kirchner's
basal medium and 0.9 ml. of the serum.
In the modified Kirchner's basal medium, all ingredients were added to 10
times of the original concentration.
These media (1.0 ml.) were inoculated with 0.025 mg. of H37Rv and were
incubated at 37°C for four weeks.
Results:
As may be seen in Table 4, the tuberculostatic activity of the sera was re-
cognized up to 5 or 7 hours after administration of KM alone. The combined
use of KM and CS resulted in a longer antituberculous effect compared with the
single use of KM.
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Kanamycin 20 mg. per kg.





Kanamycin 20 mg. per kg.
and
Cycloserine 20 mg. per kg.





(IV) The antituberculous activity of KM-CS on the experimental tuberculosis.
A) The experiment with ocular tuberculosis of guinea pigs.
Methods:
Guinea pigs, each weighing approximately 500 g. and negative to tuberculin
skin reaction (0.1 cc. of 1: 100 diluted a.T.), were inoculated subcutaneously in
the groin with 0.1 mg. (wet weight) of H 37Rv. Four weeks after inoculation,
Table 5. Index of Experimental Tuberculous Lesions in the Anterior Segments of
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when the positive conversion of tuberculin skin reaction was confirmed in all
guinea pigs, the anterior chambers of their right eyes were punctured and inocu-
lated with 0.002 mg. (wet weight) of the same strain in order to produce the
experimental ocular tuberculosis. The development of the ocular tuberculous
lesions were precisely followed by means of hand slit-lamp examination and
recorded the index of lesions of each animal.
The severity of the tuberculous lesions in the anterior segment of the eye
was graded by the index of W. Steenken Jr. et a1. 8 \ modified by M. Naito et al,9)
as shown in Table 5.
When the moderately advanced tuberculous ocular lesions were observed, a
week after the intraocular inoculation, the animals were divided into three groups.
Each group involved six guinea pigs and the arithmetic mean of the indices was
regarded as the index of the group at that time.
Group 1: KM 20 mg.jkg. three times a week (subcutaneously)
Group 2: KM 20 mg.jkg. three times a week (subcutaneously)·
CS 10 mg.jkg. daily (orally)
Group 3: Control
The administration of the drugs started on the day of grouping the animals
and continued for eight weeks. The mean values of tuberculosis indices of the
ocular lesions in each group were plotted successively.
Results:
As shown in Fig. 1, though KM used with CS in the treatment of ocular
tuberculosis of guinea pigs seemed to be effective, marked difference in the
therapeutic effect between KM-CS and KM alone was not observed.
B) The experiment with the survival time of tuberculous mice administered
KM and/or CS.
Methods:
Inbred female mice (dd-strain), each weighing 18 to 20 gm., were inoculated
intravenously with 0.5 mg. (wet weight) of Mycobacterium tuberculosis var. hominis







KM 20 mg./kg. twice a week, subcutaneously
CS 10 mg.jkg. daily, orally
KM 10 mg./kg. twice a week +CS 5 mg./kg. every day
KM 20 mg./kg. twice a week I CS 10 mg.jkg. every day
Control
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Figure 1. The grade of the Tuberculose Lesions in the
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The administration of the drugs started on the following day of the intra-
venous inoculation of tubercle bacilli and was kept along until a half of mice of
anyone of the treated groups were dead. The number of dead mice was plotted
on the graph.
Results:
In this experiment, KM 20 mg./kg. used with CS 10 mg./kg. was most effective
(Fig. 2). And KM 10 mg./kg. used with CS 5 mg./kg. showed slightly less effec-
tive than KM 20 mg./kg. alone. Mean survival time in days is shown in Fig. 2.
Discussion and Summary
It is recognized that pulmonary tuberculosis patients who are excreting
tubercle bacilli resistant to SM, PAS and/or INH, have been increasing in number.
Though this may be caused by failure of previous chemotherapy or by infection
with drug-resistant tubercle bacilli, the treatment to these patients is one of the
most difficult tasks in the tuberculosis clinic.
In the experiments described above, it was shown that KM used with CS
exhibited the definite synergistic effects in vitro and the development of bacterial
resistance to KM was evidently prolonged d.ue to the combined use of KM and CS.
The fact that the MIC of KM is much more influenced by the size of inoculum
and the pH of culture media than is CS, should be noted. The apparent similarity
of the effects of pH and inoculum size on KM and SM deserves further investi-
gation.
The bacteriostatic activity of the serum after the administration of KM-CS
was maintained longer than that of KM alone which may indicate the availability
of the combined use of these two drugs in tuberculosis clinics.
Although the survival rate of tuberculous mice administered both KM and
CS showed a remarkable synergistic effect, the influence of the combined use of
these two drugs on the ocular tuberculous lesions of guinea pigs was not remark-
ably better than that of KM or CS alone. As for the discrepancy between the
results of these two experiments in animals, it might be attributable to the
differences in the size of inoculum and the dosage of the drugs administered.
The clinical effect of the regimen of KM and CS in the treatment of serious
pulmonary tuberculosis will be reported in the near future.
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